Collection
Pre-clinical and in vitro studies
- Submission status
- Open
- Open for submission from
- 09 February 2023
- Submission deadline
- Ongoing
A collection of in vitro and animal studies on promising drugs to treat important diseases.
Editors
-
Dr Veli-Pekka Ranta
Veli-Pekka Ranta, Ph.D., Pharm., is Senior Lecturer in Pharmacokinetics at the University of Eastern Finland. His research interests include pre-clinical and clinical pharmacokinetics of systemic and ocular drugs combined with advanced modeling such as population pharmacokinetics and three-dimensional computational fluid dynamics.
Articles (4 in this collection)
-
-
Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome
Authors (first, second and last of 6)
- Shuangyan Yang
- Junfeng Zhang
- Lili Song
- Content type: Original Research Article
- Open Access
- Published: 22 September 2022
- Pages: 271 - 279
-
Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9
Authors (first, second and last of 5)
- Theodore J. Kottom
- Kyle Schaefbauer
- Andrew H. Limper
- Content type: Original Research Article
- Open Access
- Published: 29 April 2022
- Pages: 165 - 173
-
NLRP3 Inhibitor Tranilast Attenuates Gestational Diabetes Mellitus in a Genetic Mouse Model
Authors
- Jing Cao
- Qian Peng
- Content type: Original Research Article
- Open Access
- Published: 05 February 2022
- Pages: 105 - 112